Reckitt Benckiser Group PLC — Director's Dealing 2024

Mar 7, 2024

National Storage Mechanism | Additional information

RNS Number : 0074G

Reckitt Benckiser Group PLC

07 March 2024

7 March 2024

RECKITT BENCKISER GROUP PLC

DIRECTOR/PDMR SHAREHOLDING

The following notifications are made in accordance with DTR 3.1.2-A, incorporating article 19(1) of the Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Susan Sholtis

2

Reason for the notification

a)

Position/status

President Nutrition

b)

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

American Depositary Receipts (Five (5) American Depositary Receipts are equivalent to one (1) Ordinary share of 10 pence each in Reckitt Benckiser Group PLC)

CUSIP number: 756255204

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$13.01	17,000

d)

Aggregated information

-       Aggregated volume

-       Price

Aggregate Price	Aggregate Volume	Aggregate Total
$13.01	17,000	$221,170

e)

Date of the transaction

2024-03-05

f)

Place of the transaction

United States - OTC Exchange

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

American Depositary Receipts (Five (5) American Depositary Receipts are equivalent to one (1) Ordinary share of 10 pence each in Reckitt Benckiser Group PLC)

CUSIP number: 756255204

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$13.005	500

d)

Aggregated information

-       Aggregated volume

-       Price

Aggregate Price	Aggregate Volume	Aggregate Total
$13.005	500	$6,502.50

e)

Date of the transaction

2024-03-05

f)

Place of the transaction

United States - OTC Exchange

For further Information:

Catheryn O'Rourke

Company Secretary

Tel +44 (0) 1753 217 800

Richard Joyce

Head of Investor Relations

Tel. +44 (0) 7408 812062

About Reckitt:

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society.  Find out more, or get in touch with us at www.reckitt.com

* Reckitt is the trading name of the Reckitt Benckiser group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBGGDXRDGDGSR